Quotient Sciences

Website overhaul to support global rebrand

Supporting Quotient through change

World-leading pharmaceutical company, Quotient Sciences, is focused on drug development and the acceleration of  manufacturing to dramatically reduce drug delivery times.

In partnership spanning four years, Onespacemedia has worked on a range of projects, including websites for We Need You and Go Participate Nowdriving clinical trial activities in both the UK and US.

This latest website, in collaboration with Peter Economides - of Apple notoriety - represents a complete overhaul to support a global rebrand.

Managing a collaborative stakeholder process

The project involved a complex, international stakeholder process including multiple departments within Quotient Sciences, as well as Quotient's external suppliers.

We used a range of third party collaboration tools to streamline communications, manage expectations and above all maximise efficiency.

A research driven iterative design process

The Onespacemedia design team used AI software to reveal how potential users may browse and engage with content. This data-driven approach to user experience and design decisions guided strategies for improved customer engagement.

Creating a cohesive design system

Working in collaboration with Quotient's branding agency we created a cohesive design system across all assets - both on and offline. Designing a collection of repeatable elements - e.g. type, colour, iconography and interactions - ensuring consistency across the whole platform as well as efficiencies that will provide time and cost savings in the future.

“Yet again, Onespacemedia have delivered the website development project to a high standard, ensuring deadlines are comfortably met and the website launch went smoothly. They are professional and knowledgeable, and always a pleasure to work with. Robin Bodicoat, Marketing Director, Quotient Sciences”

This site uses cookies in accordance with our privacy policy. By continuing to use this site, you agree to these terms.